Abstract
We performed a retrospective observational study to examine the incidence of invasive aspergillosis (IA) among allogeneic hematopoietic stem cell transplant (HSCT) recipients, according to whether patients received at least 1 week of voriconazole prophylaxis. We report no cases of IA among 92 HSCT recipients who received voriconazole prophylaxis compared with a 10% (23/223) incidence among those receiving other systemic antifungals for prophylaxis (P < .0005). © 2006 Elsevier Inc. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Siwek, G. T., Pfaller, M. A., Polgreen, P. M., Cobb, S., Hoth, P., Magalheas-Silverman, M., & Diekema, D. J. (2006). Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. Diagnostic Microbiology and Infectious Disease, 55(3), 209–212. https://doi.org/10.1016/j.diagmicrobio.2006.01.018
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
